Improving Access to Clinical Trials Act of 2009

Never voted on. It didn't reach a floor vote before the 111th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

EMD MarkeySponsor

142 cosponsors · 88 D, 54 R

MBD Berry GBR Brown-Waite CBR Boustany KCR Conaway SCD Cohen DDD DeGette RDD DeLauro NDD Dicks MDD Doyle BGD Gordon GGD Green LJR Jenkins PKR King JLD Lewis JMD McGovern JMD Moran KMD Meek CMD Murphy JOD Olver RPR Paul MRD Ross MRR Rogers PSD Stark CSR Stearns JSD Schakowsky ASD Schwartz HWD Waxman RWD Wexler EWR Whitfield MBR Burgess JMD McNerney PTR Tiberi JFR Fleming PGD Griffith MMD McIntyre EBD Blumenauer CBD Brown RHD Holt FPD Pallone SBR Bachus DKD Kildee MBR Bono Mack TBD Baldwin AGD Grayson JMD Marshall RAR Alexander TMR McCotter HBD Berman BLD Lee RBD Boucher JBR Bonner BFD Filner BFD Frank TPR Platts LSD Sánchez MHD Hinchey JAD Altmire DMR Manzullo BMD McCollum SLR LaTourette SKD Kosmas LWD Woolsey SLD Levin BMD Markey JSD Sarbanes BMD Miller DWD Wasserman Schultz PWD Welch BED Ellsworth JID Inslee SMR Myrick NTD Tsongas SGR Graves ZLD Lofgren SBD Berkley DPD Price RBR Blunt ECD Cleaver AHD Hastings PKD Kennedy DMD Moore ACR Crenshaw HBR Brown BBD Braley LDD Doggett PRR Roskam JSD Spratt CYR Young JWR Wilson RHR Hall CLR Lee JMR Moran MMR McCaul DTD Titus JSD Sestak RKD Klein TRD Ryan PGR Gingrey JPD Polis DMD Matsui BCR Cassidy MRR Rogers JHD Himes JYD Yarmuth RBR Bartlett ASD Schiff CVD Van Hollen NLD Lowey DYR Young ASR Schock DWD Wu TMR Murphy JPR Pitts TTR Tiahrt LCD Capps SRD Rothman RBR Bishop VER Ehlers IRR Ros-Lehtinen LWR Westmoreland SDD Davis GWR Walden BSD Sutton MCD Capuano MBR Blackburn JAR Ann Emerson JGD Garamendi EPR Paulsen FWR Wolf KSD Schrader BPD Pascrell PHD Hare JLD Larson GDR Davis JTD Tierney GPD Peters SAR Austria JBD Barrow GBR Bilirakis HCR Coble BED Etheridge MJD Jo Kilroy

29 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

Improving Access to Clinical Trials Act of 2009 - Amends title XVI (Supplemental Security Income) (SSI) of the Social Security Act to disregard for SSI income eligibility purposes any compensation in the amount of the first $2,000 per year received by an individual for participation in clinical trials for rare diseases or conditions.